Timeline

The following timeline provides an overview of the developmental milestones for the Curetrax platform. This timeline will be updated regularly to reflect the current completion progress of Curetrax’s products.

  • October 2020

    Start with an Idea and Find The Right People

    After more than 6 months into the COVID-19 pandemic, it became clear that endless unstructured phone consults with patients after stem cell transplantation could become much more informative and efficient if relevant health data could be collected in real-time.

  • January 2021

    Platform Design

    Determining the requirements for Curetrax’s first product, CuretraxAllo. Once the requirements for this specific patient population are clearly understood, product design can commence.

    January 2021

  • November 2021

    Development of the Mobile and Web Apps Intended for Patients

  • October 2021

    Development of the Web Apps Intended for Healthcare Providers

    October 2021

  • July 2022

    Development of the Back End Infrastructure

    Considering the sensitivity of the data being stored and transmitted within the Curetrax platform, great care and attention is required to ensure patient privacy is maintained. Thus, our back end infrastructure was developed with this being the number one priority.

  • September 2022

    Pilot Study Design

    September 2022

  • November 2022

    HIPAA Compliancy Project started

    Completion of HIPAA training which ensures Curetrax’s staff and platform are compliant with the regulations specified in HIPAA.

  • February 2023

    Completion of Mobile Application CuretraxAllo

    Upon the completion of the development of the Curetrax platform and all required training, Curetrax’s first product, CuretraxAllo, will be formally ready for external testing in the healthcare setting.

    February 2023

  • August 2023

    Completion of the Physician´s Dashboard

    Full visualistion of the data obtained from the wearable device and the manual symptome reporting to health care takers.

  • November 2023

    Completion of Medication Plan

    Interactive Medication Plan added. Healthcare providers can now adjust medications and the patient will be notified. The patient has to acknowledge the change and the healthcare provider will be informed.

    November 2023

  • December 2023

    CAR CD19 Application Development started

    Our second product development has started. We will build an application designed to allow for home monitoring of patients after CAR T-cell therapy targeting the CD19 antigen. This development will be fully patient centered and in collaboration with patient groups.

  • May 2024

    Funding obtained for 1st CuretraxAllo Clinical Trial

    We received an CTTC/LLSC grant funding our first double center trial in Canada in patients after allogeneic stem cell transplantation using our CuretraxAllo application.

    May 2024

  • June 2024

    Implementation of a Discussion Tool in CuretraxAllo

    In order to be able to discuss patient data among healthcare providers the Physisican´s Dashboard will provide a video and screensharing tool.

  • August 2024

    Completion of CuretraxCAR19 Mobile App

    Completion of CuretraxCAR19 mobile phone application for patients after  CAR T-cell therapy targting the CD19 antigen.

    August 2024

  • September 2024

    Multi-Language Capability

    We have now integrated multi-language capabilities allowing patients to choose between English, Francais, Deutsch and Espanol. Presto seguirà l’italiano!

  • October 2024

    Research Ethics Board Application for 1st Clinical Trial Started

    We sent out our application to the Research Ethics Board for our first clinical trial.

    October 2024